Giovanni Piedimonte1, Miriam K Perez2. 1. The Cleveland Clinic, Pediatric Institute and Children's Hospital, Cleveland, OH 44195, USA. Electronic address: PIEDIMG@ccf.org. 2. The Cleveland Clinic, Pediatric Institute and Children's Hospital, Cleveland, OH 44195, USA.
Abstract
PURPOSE OF REVIEW: Respiratory syncytial virus (RSV) represents the most common respiratory pathogen observed worldwide in infants and young children and may play a role in the inception of recurrent wheezing and asthma in childhood. We discuss herein the recent hypothesis that RSV vertically transmitted from the mother to the fetus in utero causes persistent structural and functional changes in the developing lungs of the offspring, thereby predisposing to postnatal airway obstruction. RECENT FINDINGS: A number of observations in humans support the notion that extrapulmonary tissues may be infected hematogenously by RSV and harbor this virus allowing the persistence of latent infection. More recent data from animal models suggest that RSV can be transmitted across the placenta from the respiratory tract of the mother to that of the fetus, and persist in the lungs both during development, as well as during adulthood. Vertical RSV infection is associated with dysregulation of crucial neurotrophic pathways during ontogenesis, leading to aberrant parasympathetic innervation and airway hyperreactivity after postnatal reinfection. SUMMARY: These new data challenge the current paradigm that acquisition of RSV infection occurs only after birth and shift attention to the prenatal effects of the virus, with the potential to result in more severe and lasting consequences by interfering with crucial developmental processes. The most immediate implication is that prophylactic strategies targeted to the mother-fetus dyad may reduce the incidence of postviral sequelae like childhood wheezing and asthma.
PURPOSE OF REVIEW: Respiratory syncytial virus (RSV) represents the most common respiratory pathogen observed worldwide in infants and young children and may play a role in the inception of recurrent wheezing and asthma in childhood. We discuss herein the recent hypothesis that RSV vertically transmitted from the mother to the fetus in utero causes persistent structural and functional changes in the developing lungs of the offspring, thereby predisposing to postnatal airway obstruction. RECENT FINDINGS: A number of observations in humans support the notion that extrapulmonary tissues may be infected hematogenously by RSV and harbor this virus allowing the persistence of latent infection. More recent data from animal models suggest that RSV can be transmitted across the placenta from the respiratory tract of the mother to that of the fetus, and persist in the lungs both during development, as well as during adulthood. Vertical RSV infection is associated with dysregulation of crucial neurotrophic pathways during ontogenesis, leading to aberrant parasympathetic innervation and airway hyperreactivity after postnatal reinfection. SUMMARY: These new data challenge the current paradigm that acquisition of RSV infection occurs only after birth and shift attention to the prenatal effects of the virus, with the potential to result in more severe and lasting consequences by interfering with crucial developmental processes. The most immediate implication is that prophylactic strategies targeted to the mother-fetus dyad may reduce the incidence of postviral sequelae like childhood wheezing and asthma.
Authors: Maarten O Blanken; Maroeska M Rovers; Jorine M Molenaar; Pauline L Winkler-Seinstra; Adam Meijer; Jan L L Kimpen; Louis Bont Journal: N Engl J Med Date: 2013-05-09 Impact factor: 91.245
Authors: R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez Journal: Lancet Date: 1999-08-14 Impact factor: 79.321
Authors: Bikul Das; Suely S Kashino; Ista Pulu; Deepjyoti Kalita; Vijay Swami; Herman Yeger; Dean W Felsher; Antonio Campos-Neto Journal: Sci Transl Med Date: 2013-01-30 Impact factor: 17.956
Authors: Eric A F Simões; Xavier Carbonell-Estrany; Christian H L Rieger; Ian Mitchell; Linda Fredrick; Jessie R Groothuis Journal: J Allergy Clin Immunol Date: 2010-07-10 Impact factor: 10.793
Authors: Xiufang Zheng; Lisha Wang; Baoxia Wang; Kun Miao; Kunlun Xiang; Song Feng; Lu Gao; Hong C Shen; Hongying Yun Journal: ACS Med Chem Lett Date: 2016-04-20 Impact factor: 4.345
Authors: Viviana Sampayo-Escobar; Ryan Green; Michael B Cheung; Raminder Bedi; Subhra Mohapatra; Shyam S Mohapatra Journal: PLoS One Date: 2018-04-20 Impact factor: 3.240
Authors: Shabir A Madhi; Clare L Cutland; Sarah Downs; Stephanie Jones; Nadia van Niekerk; Eric A F Simoes; Marta C Nunes Journal: Clin Infect Dis Date: 2018-05-17 Impact factor: 9.079
Authors: Kiramage Chathuranga; Myun Soo Kim; Hyun-Cheol Lee; Tae-Hwan Kim; Jae-Hoon Kim; W A Gayan Chathuranga; Pathum Ekanayaka; H M S M Wijerathne; Won-Kyung Cho; Hong Ik Kim; Jin Yeul Ma; Jong-Soo Lee Journal: Viruses Date: 2019-07-03 Impact factor: 5.048
Authors: Koen B Pouwels; Sefika E Bozdemir; Selen Yegenoglu; Solmaz Celebi; E David McIntosh; Serhat Unal; Maarten J Postma; Mustafa Hacimustafaoglu Journal: PLoS One Date: 2016-09-30 Impact factor: 3.240